ArticleJournal of Cancer2019

Disease-specific haptoglobin-β chain N-glycosylation as biomarker to differentiate non-small cell lung cancer from benign lung diseases.

Tianjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.